Correction: Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study
Titel:
Correction: Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study
Auteur:
Zager, Jonathan S. Orloff, Marlana Ferrucci, Pier Francesco Choi, Junsung Eschelman, David J. Glazer, Evan S. Ejaz, Aslam Howard, J. Harrison Richtig, Erika Ochsenreither, Sebastian Reddy, Sunil A. Lowe, Michael C. Beasley, Georgia M. Gesierich, Anja Bender, Armin Gschnell, Martin Dummer, Reinhard Rivoire, Michel Arance, Ana Fenwick, Stephen William Sacco, Joseph J. Haferkamp, Sebastian Weishaupt, Carsten John, Johnny Wheater, Matthew Ottensmeier, Christian H.